Zobrazeno 1 - 10
of 211
pro vyhledávání: '"Lung‐Yi Mak"'
Autor:
Lung-Yi Mak
Publikováno v:
Journal of Liver Cancer, Vol 24, Iss 2, Pp 145-154 (2024)
Chronic hepatitis B (CHB) infection is responsible for 40% of the global burden of hepatocellular carcinoma (HCC) with a high case fatality rate. The risk of HCC differs among CHB subjects owing to differences in host and viral factors. Modifiable ri
Externí odkaz:
https://doaj.org/article/a3578b608baa4a8084eb2d9961e31139
Autor:
Philip Leung Ho Yu, Keith Wan-Hang Chiu, Jianliang Lu, Gilbert C.S. Lui, Jian Zhou, Ho-Ming Cheng, Xianhua Mao, Juan Wu, Xin-Ping Shen, King Ming Kwok, Wai Kuen Kan, Y.C. Ho, Hung Tat Chan, Peng Xiao, Lung-Yi Mak, Vivien W.M. Tsui, Cynthia Hui, Pui Mei Lam, Zijie Deng, Jiaqi Guo, Li Ni, Jinhua Huang, Sarah Yu, Chengzhi Peng, Wai Keung Li, Man-Fung Yuen, Wai-Kay Seto
Publikováno v:
JHEP Reports, Vol 7, Iss 1, Pp 101219- (2025)
Background & Aims: Hepatocellular carcinoma (HCC) is characterized by a high mortality rate. The Liver Imaging Reporting and Data System (LI-RADS) results in a considerable number of indeterminate observations, rendering an accurate diagnosis difficu
Externí odkaz:
https://doaj.org/article/e310a2c520834a86801fd57090659381
Autor:
Lung-Yi Mak
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 2, Pp 171-173 (2024)
Externí odkaz:
https://doaj.org/article/b2386fd8438143809534c77f27c14df7
Publikováno v:
F1000Research, Vol 13 (2024)
Advanced hepatocellular carcinoma (HCC) is traditionally associated with limited treatment options and a poor prognosis. Sorafenib, a multiple tyrosine kinase inhibitor, was introduced in 2007 as a first-in-class systemic agent for advanced HCC. Afte
Externí odkaz:
https://doaj.org/article/6ed9dec2e5e345eb89497562f4af2ba9
Autor:
Yu Chen, Lung-Yi Mak, Mary H.Y. Tang, Jingyi Yang, Chun Bong Chow, Ai-Ming Tan, Tao Lyu, Juan Wu, Qingjuan Huang, Hai-Bo Huang, Ka-Shing Cheung, Man-Fung Yuen, Wai-Kay Seto
Publikováno v:
JHEP Reports, Vol 6, Iss 5, Pp 101050- (2024)
Background & Aims: Peripartum prophylaxis (PP) with tenofovir disoproxil fumarate (TDF) is the standard of care to prevent mother-to-child transmission of chronic hepatitis B (CHB) infection in mothers who are highly viremic. We investigated the mate
Externí odkaz:
https://doaj.org/article/1a48b04580e641f2a0e84784489839fe
Autor:
Saisai Zhang, Hau-Tak Chau, Hein Min Tun, Fung-Yu Huang, Danny Ka-Ho Wong, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
Publikováno v:
EBioMedicine, Vol 103, Iss , Pp 105101- (2024)
Summary: Background: Gut dysbiosis is present in chronic hepatitis B virus (HBV) infection. In this study, we integrated microbiome and metabolome analysis to investigate the role of gut microbiome in virological response to nucleos(t)ide analogues (
Externí odkaz:
https://doaj.org/article/38380c530e3a449aa6cf857fb066824d
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background and Aim : In chronic hepatitis B infection (CHB), seroclearance of hepatitis B surface antigen (HBsAg) is associated with favourable clinical outcomes compared to those with persistent HBsAg seropositivity, and thus considered as
Externí odkaz:
https://doaj.org/article/77ad0844263d4263a3847f278f4c92fb
Autor:
Lung-Yi Mak, Albert CY Chan, Tiffany CL Wong, Wing-Chiu Dai, Wong-Hoi She, Ka-Wing Ma, Sui-Ling Sin, Ka-Wan Chu, Wai-Kay Seto, Man-Fung Yuen, Chung-Mau Lo, James Fung
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background & Aims Although non-alcoholic fatty liver disease (NAFLD) remains an uncommon indication for liver transplantation (LT) in the Chinese, the prevalence of NAFLD is increasing. We aimed to determine the prevalence of de novo steatos
Externí odkaz:
https://doaj.org/article/ccd63cc1f85e401087cef84177be3ef7
Autor:
Lok-Ka Lam, Thomas Sau Yan Chan, Yu-Yan Hwang, Lung-Yi Mak, Wai-Kay Seto, Yok-Lam Kwong, Man-Fung Yuen
Publikováno v:
Virology Journal, Vol 20, Iss 1, Pp 1-4 (2023)
Abstract Background Ibrutinib is a Bruton’s tyrosine kinase (BTK) inhibitor approved for the treatment for several mature B-cell malignancies. Reactivation of hepatitis B virus (HBV) is a well-described complication in patients with chronic HBV inf
Externí odkaz:
https://doaj.org/article/cc05b311d10c40598f58c56123be4618
Publikováno v:
Clinical and Molecular Hepatology, Vol 29, Iss 2, Pp 217-229 (2023)
Hepatocellular carcinoma (HCC) is a major public health burden in Hong Kong, and chronic hepatitis B is the most common HCC etiology in our region. With the high case load, extensive local expertise on HCC has been accumulated. This article summarize
Externí odkaz:
https://doaj.org/article/bec48d09e47f4749a73e9a04b01a0d76